Ben Gil Price, Director at Sarepta Therapeutics, holds 15.00K shares in Ocuphire Pharma (Ticker: OCUP), holds 37.33K shares in Sarepta Therapeutics (Ticker: SRPT), holds ― shares in NeuroBo Pharmaceuticals (Ticker: NRBO). Most recently, Ben Gil Price Bought ― shares of Ocuphire Pharma on Jan 31, 2019 for an estimated value of 9.00K.